Work

Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies

Year: 2017

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.1353.1353

Authors: Aaron D. Goldberg, Troy Z. Horvat, Meier Hsu, Sean M. Devlin, Bernadette M. Cuello, Ryan J. Daley, Amber C. King, Larry W. Buie, Jacob L. Glass, Michael J. Mauro, Eytan M. Stein, Ellin Berman, Virginia M. Klimek, Martin S. Tallman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2948922537

FWCI: 1.81

Cites:

Cited by: 23

Related to: 20